Michael Lill, MBBS, FRACP, FRCPA

Medical Director, Blood and Marrow Transplant Program

Professor of Medicine

Michael Lill, MBBS, FRACP, FRCPA, is medical director of the Cedars-Sinai Blood and Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute. He is a professor of Medicine at Cedars-Sinai and at UCLA.

Dr. Lill is qualified in hematology and hematopathology, and treats patients with cancers of the blood and bone marrow, including leukemia, lymphoma, multiple myeloma and myelodysplastic syndrome. He has particular expertise in the transplantation of hematopoietic (bone marrow) stem cells to restore normal bone marrow function after high-dose chemotherapy and/or radiation. He has also developed a nationally leading program in bloodless stem cell transplantation for Jehovah's Witnesses.

Dr. Lill is a frequent participant in clinical trials of new cancer chemotherapies and potential improvements in blood and marrow transplantation. His expertise in stem cell collection was tapped by the Cedars-Sinai Heart Institute for a study testing whether bone marrow stem cells could be used to regenerate cardiac tissue after a heart attack.

Publications by Dr. Lill include many chapters in medical textbooks. He has coauthored articles published in numerous peer-reviewed medical journals: Blood, Stem Cells, Journal of Hematotherapy, Bone Marrow Transplantation, Leukemia and others.

Dr. Lill is a member of the American Society of Hematology, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, and American Medical Association. He is a member of numerous national committees including the board of directors of the Foundation for the Accreditation of Cellular Therapy, the main accrediting body for stem cell transplantation and is helping to develop standards for regenerative medicine for that organization. He has been included among the "Best Doctors in America" more than 10 times. He is a fellow of the Royal Australian College of Physicians and the Royal College of Pathologists of Australia.

After receiving his medical degree at the University of Western Australia in Perth, Dr. Lill received his training in general internal medicine, hematology and hematopathology at Sir Charles Gairdner Hospital and Royal Perth Hospital in Perth, Western Australia. Upon completion of his specialist training in Australia, he moved to UCLA where he was a visiting assistant professor for two years before joining the fulltime faculty in 1991 in the blood and marrow transplant program.

He was recruited to Cedars-Sinai Medical Center in 1997, where he has held a number of posts including director of Hematopoietic Stem Cell Transplantation and medical director of Cedars-Sinai's outpatient cancer center, now the Samuel Oschin Comprehensive Cancer Institute.

Dr. Lill holds dual citizenship in Australia and the United States. He is licensed to practice medicine in the state of California and is certified by the Educational Commission for Foreign Medical Graduates.